Patterson Sandra
SEC CIK 1968906 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | SVP, Controllership | 39.5K | — | — | 25 | 2023-03-10 | 2025-03-10 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Patterson Sandra made no open-market trades at GILD in the last 12 months.
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $117.21 | -624 | 39.5K | -2% | -$73.1K |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +1,952 | 40.1K | +5% | — |
| 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | A - Grant | $0.00 | +709 | 37.8K | +2% | $0 | |
| DM | 2024-12-16 | 2023-12-13+ | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +455 | 37.5K | +1% | — |
| DM | 2024-12-16 | 2023-12-13+ | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $86.12 | -455 | 37.1K | -1% | -$39.2K |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $92.34 | -408 | 37.1K | -1% | -$37.7K |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +901 | 37.5K | +2% | — |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $81.44 | -292 | 36.6K | -0.8% | -$23.8K |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +901 | 36.9K | +3% | — |
| D | 2024-08-12 | 2024-08-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $73.66 | -980 | 36.0K | -3% | -$72.2K |
| D | 2024-08-12 | 2024-08-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +3,678 | 37.0K | +11% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $65.25 | -255 | 33.3K | -0.8% | -$16.6K |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +901 | 33.5K | +3% | — |
| DM | 2024-03-12 | 2024-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +2,682 | 33.4K | +9% | — |
| D | 2024-03-12 | 2024-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $75.12 | -790 | 32.6K | -2% | -$59.3K |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $79.02 | -222 | 30.4K | -0.7% | -$17.5K |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +518 | 30.6K | +2% | — |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $76.00 | -149 | 30.1K | -0.5% | -$11.3K |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +519 | 30.3K | +2% | — |
| D | 2023-08-11 | 2023-08-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $80.00 | -1,306 | 29.8K | -4% | -$104.5K |
| D | 2023-08-11 | 2023-08-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +4,484 | 31.1K | +17% | — |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $78.12 | -153 | 26.6K | -0.6% | -$12.0K |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +517 | 26.7K | +2% | — |
| DM | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | M - OptEx | — | +2,921 | 25.7K | +13% | — |
| D | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Patterson Sandra | SVP, Controllership | F - Tax | $79.50 | -801 | 26.2K | -3% | -$63.7K |
Purchase Sale Sale after option exercise All abbreviations